TITLE

The Assessment of Fracture Risk

AUTHOR(S)
Unnanuntana, Aasis; Gladnick, Brian P.; Donnelly, Eve; Lane, Joseph M.
PUB. DATE
March 2010
SOURCE
Journal of Bone & Joint Surgery, American Volume;Mar2010, Vol. 92-A Issue 3, p743
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the calculation of age-specific fracture probabilities in men and women through the Fracture Risk Assessment Tool (FRAX). Patients with bone mineral density in the osteopenic range usually have fragility fractures. The efficacy of antiresorptive or anabolic therapy can be monitored through biochemical bone markers.
ACCESSION #
48681480

 

Related Articles

  • Osteoporosis, Fracture Risk, and Prosthodontic Implications. Koka, Sreenivas; Salinas, Thomas J.; Kennel, Kurt A. // International Journal of Prosthodontics;2009, Vol. 22 Issue 5, p505 

    The article presents an overview of osteoporosis, which is a disease characterized by low bone mass and deterioration of bone tissue which can lead to bone fragility and an increased susceptibility of fractures. A discussion of medications which can be used to treat osteoporosis, and of the...

  • New horizons in fracture risk assessment. Aspray, Terry J. // Age & Ageing;Sep2013, Vol. 42 Issue 5, p548 

    Fracture is the clinical outcome of concern in osteoporosis, a disease variably defined over the last 30 years, mostly in terms of bone mineral density (BMD). However, an ‘osseocentric’ view of the condition may have hampered our understanding of how best to identify patients at the...

  • Three-Year Experience with Risedronate Therapy for Patients with an Increased Fracture Risk. Takakuwa, Masayuki; Iwamoto, Jun; Itabashi, Koichi // Clinical Drug Investigation;2012, Vol. 32 Issue 2, p121 

    Background and Objective: We previously reported that risedronate improved the structural parameters of the proximal femur, as well as lumbar spine and proximal femoral bone mineral density (BMD), after l year of therapy by suppressing bone resorption in patients with an increased risk of...

  • Fracture risk prediction with FRAX in Slovak postmenopausal women. Némethová, Eva; Killinger, Zdenko; Payer, Juraj // Central European Journal of Medicine;Oct2013, Vol. 8 Issue 5, p571 

    Introduction: Current Slovak treatment thresholds in osteoporosis are based on bone mineral density (BMD) or a previous fracture. Some patients at high risk for fractures may not be identified. FRAX (Fracture Risk Assessment Tool) is based on patient risk profile assessment and calculates...

  • Bone density testing.  // Mayo Clinic Health Letter;Mar2015, Vol. 33 Issue 3, p6 

    The article discusses the use of bone density testing in diagnosing osteoporosis. Topics covered include the development of bone-thinning osteoporosis as a serious health issue in some men and many older women, the use of the Fracture Risk Assessment Tool (FRAX) to assess the risk of fracture or...

  • Osteoporosis: A Review. Danielson, Laura; Zamulko, Alla // South Dakota Medicine;Nov2015, Vol. 68 Issue 11, p503 

    Osteoporosis is a silent disease which can significantly increase an individual's risk of fracture. Fractures can be physically debilitating and consequently cause a financial burden on the patient, so it is key to treat osteoporosis before a fracture occurs. Osteoporosis is defined based on the...

  • Use baseline T-score to decide osteoporosis testing frequency.  // Pulse;5/16/2012, p6 

    The article discusses a study which suggests baseline T-score as the most essential frequency determinant for testing bone mineral density (BMD) in fracture-risk patients.

  • The Cost Effectiveness of Bisphosphonates for the Prevention and Treatment of Osteoporosis: A Structured Review of the Literature. Fleurence, Rachael L.; Iglesias, Cynthia P.; Johnson, Jeanene M. // PharmacoEconomics;2007, Vol. 25 Issue 11, p913 

    Osteoporotic fragility fractures constitute a significant public health concern. The lifetime risk of any osteoporotic fracture is very high (40-50% in women and 13-22% in men). Fractures are associated with significant mortality and morbidity and represent a substantial economic burden to...

  • Recent Advances in Management of Cancer Treatment-induced Bone Loss (CTIBL) in Patients with Breast or Prostate Cancer. Soo Hyun Kim; Hong Seongbin Kim; Song Youngkyu Kim; Song Hosook Kim // Asian Oncology Nursing;Sep2013, Vol. 13 Issue 3, p103 

    Purpose: Bone loss resulting from cancer treatment is an emerging problem among cancer survivors. However, the mechanism and treatment of cancer treatment-induced bone loss (CTIBL) is not fully understood. The purpose of this article was to review the recent advances in CTIBL. Methods: A...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics